|
|
 |
Robert
M. Bennett, MD,
FRCP, FACP
Dr.
Bennett is Professor of Medicine at Oregon Health and Science University
(OHSU)
in Portland, Oregon. He was born and educated in England, and did his
basic rheumatology training with Professor Eric Bywaters at the Royal
Postgraduate Medical School in London. He has lived in the USA since
1972 and did additional training with Professor Daniel McCarty at the
University of Chicago. He was Chairman of the Division of Arthritis and
Rheumatic Diseases at OHSU for 24 years (1976-2000). Dr. Bennett is
currently the Board Chairman of the International Myopain Society. He is
a past President of the International Myopain Society the American
College of Rheumatology Western Region. He and his colleagues developed
the Fibromyalgia Impact Questionnaire in 1993; it is now the most widely
used instrument for measuring disease activity in fibromyalgia patients.
He was first to report adult growth hormone [GH] deficiency in a subset
of fibromyalgia patients in 1992 and has subsequently shown the benefits
of GH replacement. He holds patents for the utilization of GH in
fibromyalgia, chronic fatigue syndrome, rheumatoid arthritis and
polymyalgia rheumatica. His bench research involves the molecular
characterization of cell surface DNA receptors (US Patent #
5,965,520). He has published over 400
articles and book
chapters. He is/has been on the editorial boards of
Pain, Arthritis and Rheumatism, Geriatrics, the Journal of
Musculoskeletal Pain and the Journal of Functional Syndromes.
|
|
